Juffermans N P, Paxton W A, Dekkers P E, Verbon A, de Jonge E, Speelman P, van Deventer S J, van der Poll T
Laboratory of Experimental Internal Medicine, University of Amsterdam, The Netherlands.
Blood. 2000 Oct 15;96(8):2649-54.
Concurrent infections in patients with human immunodeficiency virus (HIV) infection stimulate HIV replication. Chemokine receptors CXCR4 and CCR5 can act as HIV coreceptors. The authors hypothesized that concurrent infection increases the HIV load through up-regulation of CXCR4 and CCR5. Using experimental endotoxemia as a model of infection, changes in HIV coreceptor expression were assessed in 8 subjects injected with lipopolysaccharide (LPS, 4 ng/kg). The expression of CXCR4 and CCR5 on CD4(+) T cells was increased 2- to 4-fold, 4 to 6 hours after LPS injection. In whole blood in vitro, LPS induced a time- and dose-dependent increase in the expression of CXCR4 and CCR5 on CD4(+) T cells. Similar changes were observed after stimulation with cell wall components of Mycobacterium tuberculosis (lipoarabinnomannan) or Staphylococcus aureus (lipoteichoic acid), or with staphylococcal enterotoxin B. LPS increased viral infectivity of CD4-enriched peripheral blood mononuclear cells (PBMCs) with a T-tropic HIV strain. In contrast, M-tropic virus infectivity was reduced, possibly because of elevated levels of the CCR5 ligand cytokines RANTES and MIP-1beta. LPS-stimulated up-regulation of CXCR4 and CCR5 in vitro was inhibited by anti-TNF and anti-IFN gamma. Incubation with recombinant TNF or IFN gamma mimicked the LPS effect. Anti-interleukin 10 (anti-IL-10) reduced CCR5 expression, without influencing CXCR4. In accordance, rIL-10 induced up-regulation of CCR5, but not of CXCR4. Intercurrent infections during HIV infection may up-regulate CXCR4 and CCR5 on CD4(+) T cells, at least in part via the action of cytokines. Such infections may favor selectivity of HIV for CD4(+) T cells expressing CXCR4. (Blood. 2000;96:2649-2654)
人类免疫缺陷病毒(HIV)感染患者的合并感染会刺激HIV复制。趋化因子受体CXCR4和CCR5可作为HIV的共受体。作者推测合并感染通过上调CXCR4和CCR5增加HIV载量。以实验性内毒素血症作为感染模型,在8名注射脂多糖(LPS,4 ng/kg)的受试者中评估HIV共受体表达的变化。LPS注射后4至6小时,CD4(+) T细胞上CXCR4和CCR5的表达增加了2至4倍。在体外全血中,LPS诱导CD4(+) T细胞上CXCR4和CCR5的表达呈时间和剂量依赖性增加。在用结核分枝杆菌(脂阿拉伯甘露聚糖)或金黄色葡萄球菌(脂磷壁酸)的细胞壁成分刺激后,或用葡萄球菌肠毒素B刺激后,观察到类似变化。LPS增加了携带T嗜性HIV毒株的富含CD4的外周血单核细胞(PBMC)的病毒感染性。相反,M嗜性病毒的感染性降低,可能是因为CCR5配体细胞因子RANTES和MIP-1β水平升高。体外LPS刺激的CXCR4和CCR5上调被抗TNF和抗IFNγ抑制。用重组TNF或IFNγ孵育可模拟LPS的作用。抗白细胞介素10(抗IL-10)降低CCR5表达,而不影响CXCR4。相应地,rIL-10诱导CCR5上调,但不诱导CXCR4上调。HIV感染期间的合并感染可能至少部分通过细胞因子的作用上调CD4(+) T细胞上的CXCR4和CCR5。此类感染可能有利于HIV对表达CXCR4的CD4(+) T细胞的选择性。(《血液》。2000年;96:2649 - 2654)